{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:15:06Z","timestamp":1779344106024,"version":"3.51.4"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alport syndrome (AS), one of the most common hereditary kidney diseases, is caused by mutations in genes encoding the \u03b13\u2013\u03b15 chains of type IV collagen, and is characterized by persistent hematuria with or without proteinuria, sensorineural hearing loss, and ocular abnormalities. Progressive renal injury eventually leads to end-stage kidney disease (ESKD). Early interventions can dramatically delay the progression to ESKD. However, AS is often misdiagnosed, leading to mistreatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      The patient was a 4-year-2-month-old girl, who was incidentally noticed to have foamy morning urine, prompting admission to a local hospital. Repeated urinalyses detected persistent microscopic hematuria in 20 days. Then she was referred to our hospital. Given that her mother also had microscopic hematuria and her maternal grandmother had developed end-stage renal disease of unknown etiology, we excluded infection, autoimmune disorders, and other acquired causes of hematuria, and proceeded with renal biopsy and genetic testing. Electron microscopy showed focal thinning (&amp;lt;\u2009150\u2005nm) and occasional lamellation of the glomerular basement membrane, Light microscopy revealed only mild, focal mesangial proliferation. Trio whole-exome sequencing identified a reported heterozygous missense variant in\n                      <jats:italic>COL4A5<\/jats:italic>\n                      (c.1633G\u2009&amp;gt;\u2009A, p.Gly545Ser) that was inherited from the mother. The same variant was subsequently detected in the affected maternal grandmother. This change is classified as likely pathogenic according to ACMG criteria. Currently, the patient is being treated with an angiotensin-converting enzyme inhibitor (ACEI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Early renal biopsy and comprehensive genetic analysis in a child with a positive family history of renal disease allowed the expedited diagnosis of X-linked Alport syndrome (XLAS), after the detection of persistent microscopic hematuria in 20 days. Our report highlights that females heterozygous for the\n                      <jats:italic>COL4A5<\/jats:italic>\n                      (c.1633G\u2009&amp;gt;\u2009A, p.Gly545Ser) variant are not merely asymptomatic carriers but may develop renal failure, as illustrated by the disease progression in the maternal grandmother in this pedigree. The single gene\n                      <jats:italic>COL4A5<\/jats:italic>\n                      variant, c.1633G\u2009&amp;gt;\u2009A, in AS patients has been previously reported, and its identification expands the mutational spectrum associated with XLAS and may facilitate future prenatal diagnosis and early therapeutic intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1786590","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:45:45Z","timestamp":1779342345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Early diagnosis of X-linked Alport syndrome in a pediatric patient and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Yushan","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouhang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, Sichuan Province, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3","first-page":"1507","volume":"103","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e47129","DOI":"10.7759\/cureus.47129","article-title":"Alport syndrome: a comprehensive review","volume":"15","author":"Adone","year":"2023","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"841391","DOI":"10.3389\/fmed.2022.841391","article-title":"The contribution of COL4A5 splicing variants to the pathogenesis of X-linked Alport syndrome","volume":"9","author":"Yamamura","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1002\/mgg3.647","article-title":"Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome","volume":"7","author":"Zhang","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"B11","first-page":"267","article-title":"Renal prognosis in women with hereditary nephritis","volume":"23","author":"Gr\u00fcnfeld","year":"1985","journal-title":"Clin Nephrol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.1016\/j.xkme.2026.101266","article-title":"Unusual glomerular abnormalities in a patient with combined COL4A5-NPHS1 variants","volume":"8","author":"Alwan","year":"2026","journal-title":"Kidney Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1786590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:45:59Z","timestamp":1779342359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1786590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":12,"alternative-id":["10.3389\/fped.2026.1786590"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1786590","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1786590"}}